Can a smartphone app help families get loved ones faster psychosis care?
NCT ID NCT04949542
First seen Nov 12, 2025 · Last updated Jun 17, 2026 · Updated 29 times
Summary
This study tested a mobile app designed to help caregivers of young adults (ages 15-35) with early psychosis. The app provided interactive lessons to improve caregivers' knowledge and coping skills, aiming to reduce how long psychosis goes untreated. Sixty caregivers in the U.S. participated in a remote pilot trial comparing the app to existing online resources. The research focused on whether the app was acceptable and feasible, and explored its effects on family communication and treatment-seeking.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CAREGIVER TO A YOUNG ADULT WITH EARLY PSYCHOSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Behavioral Research in Technology and Engineering Center, Health Sciences, UW Medical Center
Seattle, Washington, 98195, United States
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.